Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$64,736,282
+$4,603,130 QoQ
Shares Held
1,349,516
-13.3% QoQ
Ownership
0.234%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Derivatives in RPRX
reported options exposure · as of Sep 30, 2024CallValue
$212,175
CallShares
7,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. RPRX ranks #3 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
426,723 | $141,189,839 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
162,814 | $125,796,608 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
1,349,516 | $64,736,282 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
695,276 | $52,208,274 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
556,324 | $41,312,620 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
52,884 | $27,683,187 | |
| 7 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,103,490 | $25,998,224 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,705,829 | $24,666,287 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $64,736,282 | 1,349,516 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $60,133,152 | 1,556,241 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $24,194,565 | 685,787 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $9,848,079 | 273,330 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $9,799,207 | 384,132 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $212,175 | 7,500 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $17,502,542 | 618,683 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,588,240 | 401,526 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $18,952,064 | 624,039 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $25,306,112 | 900,894 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $25,960,929 | 956,556 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $13,382,044 | 435,330 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,544,965 | 514,709 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,352,870 | 287,269 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,698,769 | 92,055 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,451,169 | 177,240 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,038,240 | 180,653 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,705,765 | 369,028 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,550,471 | 236,593 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,220,470 | 176,152 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $636,066 | 14,582 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,060,709 | 21,193 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $9,710,000 | 200,000 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||